AGP Limited (PSX:AGP)

Market Cap	51.24B
Revenue (ttm)	26.27B
Net Income (ttm)	3.12B
Shares Out	280.00M
EPS (ttm)	11.15
PE Ratio	16.42
Forward PE	12.17
Dividend	4.00 (2.19%)
Ex-Dividend Date	Mar 27, 2025

Volume	268,130
Average Volume	833,635
Open	182.10
Previous Close	183.01
Day's Range	182.10 - 187.50
52-Week Range	78.30 - 220.02
Beta	0.39
RSI	49.04
Earnings Date	Apr 25, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.